Progress in the Study of Lymph Node Metastasis in Early-stage Cervical Cancer

Abstract

Spread into regional lymph node is the major route of metastasis in cervical cancer. Although lymph node status is not involved in the International Federation of Gynecology and Obstetrics staging system of uterine cervical cancer, the presence or absence of lymph node metastasis provides important information for prognosis and treatment. In this review, we have attempted to focus on the incidence and patterns of lymph node metastasis, and the issues surrounding surgical assessment of lymph nodes. In addition, the preoperative prediction of lymph node status, as well as the intraoperative assessment by sentinel nodes will be reviewed. Finally, lymph node micrometastasis also will be discussed.

Keywords

lymph node metastasis / cervical cancer / sentinel lymph node / micrometastasis

References

[1] AllemaniC, WeirHK, CarreiraH, et al.. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25, 676, 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet, 2015, 3B5(9972): 977-1010

[2] ChenW, ZhengR, BaadePD, et al.. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132

[3] FerrandinaG, Pedone AnchoraL, GallottaV, et al.. Can We Define the Risk of Lymph Node Metastasis in Early-Stage Cervical Cancer Patients?. A Large-Scale, Retrospective Study. Ann Surg Oncol, 2017, 24(8): 2311-2318

[4] SalvoG, RamirezPT, LevenbackCF, et al.. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol, 2017, 145(1): 96-101

[5] LeeKBM, LeeJM, ParkCY, et al.. Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix. Int J Gynecol Cancer, 2006, 16(3): 1184-1187

[6] Van MeursH, VisserO, VisserMR, et al.. Frequency of pelvic lymph node metastases and parametrial involvement in stage IA2 cervical cancer: a population-based study and literature review. Int J Gynecol Cancer, 2009, 19(1): 21-26

[7] ZhouJ, RanJ, HeZY, et al.. Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, I Bl, and II Al Uterine Cervical Cancer. J Cancer, 2015, 6(4): 377-381

[8] SakuragiN. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol, 2007, 12(3): 165-175

[9] GienLT, CovensA. Lymph node assessment in cervical cancer: prognostic and therapeutic implications. J Surg Oncol, 2009, 99(4): 242-247

[10] Benedetti-PaniciP, ManeschiF, ScambiaG, et al.. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol, 1996, 62: 19-24

[11] Benedetti-PaniciP, ManeschiF, D’AndreaG, et al.. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer, 2000, 88(10): 2267-2274

[12] LeeJM, LeeKB, LeeSK, et al.. Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage I B cervical cancer. J Obstet Gynaecol Re, 2007, 33(3): 288-293

[13] LiD, CaiJ, KuangY, et al.. Surgical-pathologic risk factors of pelvic lymph node metastasis in stage I b1–II b cervical cancer. Acta Obstet Gynecol Scand, 2012, 91(7): 802-809

[14] ZhangHY, ShengXG, ZhongY, et al.. The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma. Chin J Oncol, 2008, 30(6): 452-455

[15] DelgadoG, BundyBN, FowlerWC, et al.. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol, 1989, 35(3): 314-320

[16] KhunamornpongS, SettakornJ, SukpanK, et al.. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis. Gynecol Oncol, 2009, 112(1): 241-247

[17] ZaganelliFL, CarvalhoFM, AlmeidaBG, et al.. Intratumoral lymphatic vessel density and clinicopathologic features of patients with earlystage cervical cancer after radical hysterectomy. Int J Gynecol Cancer, 2010, 20(7): 1225-1231

[18] SunJR, ZhangYN, SunXM, et al.. Prediction model of pelvic lymph node metastasis in early stage cervical cancer and its clinical value. Minerva Chir, 2011, 66(6): 537-545

[19] LiuT, YangM, YangS, et al.. Metastasis-associated protein 1 is a novel marker predicting survival and lymph nodes metastasis in cervical cancer. Hum Pathol, 2013, 44(10): 2275-2281

[20] WangW, JiaHL, HuangJM, et al.. Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics. Br J Cancer, 2014, 10(7): 1748-1758

[21] KimDY, ShimSH, KimSO, et al.. Preoperative nomogram for the identification of lymph node metastasis in early cervical cancer. Br J Cancer, 2014, 110(1): 34-41

[22] TogamiS, KamioM, YanazumeS, et al.. Can pelvic lymphadenectomy be omitted in stage I A2 to II B uterine cervical cancer. Int J Gynecol Cancer, 2014, 24(6): 1072-1076

[23] YanaranopM, SathapornteeraN, NakrangseeS. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy. J Med Assoc Thai, 2014, 97: S87-S95

[24] LiuY, ZhaoLJ, LiMZ, et al.. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage I A–II B Cervical Squamous Cell Carcinoma. Chin Med J, 2015, 128(15): 2084-2089

[25] YangS, LiuY, XiaB, et al.. DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer. Tumour Biol, 2016, 37(4): 5063-5074

[26] WangY, YaoT, YuJ, et al.. Can pelvic lymphadenectomy be omitted in patients with stage IA2, I Bl, and IIA1 squamous cell cervical cancer. Springer Plus, 2016, 5(1): 1262

[27] CaoS, SunJ, LinS, et al.. HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer. Onco Targets Ther, 2017, 10: 4205-4211

[28] XuD, WangD, WangS, et al.. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis. Int J Gynecol Cancer, 2017, 27(9): 1935-1942

[29] SartoriE, TisiG, ChiudinelliF, et al.. Early stage cervical cancer: Adjuvant treatment in negative lymph node cases. Gynecol Oncol, 2007, 107(1): S170-S174

[30] PieterseQD, KenterGG, GaarenstroomKN, et al.. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol, 2007, 33(2): 216-221

[31] ShahM, LewinSN, DeutschI, et al.. Therapeutic Role of Lymphadenectomy for Cervical Cancer. Cancer, 2011, 117(2): 310-317

[32] FolienM, LevenbackCF, IyerRB, et al.. Imaging in cervical cancer. Cancer, 2003, 98(9): 2028-2038

[33] ChungHH, KangSB, ChoJY, et al.. Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer. Jpn J Clin Oncol, 2007, 37(5): 370-375

[34] Kinkel. Pitfalls in staging uterine neoplasm with imaging: a review. Abdom Imaging, 2006, 31(2): 164-173

[35] SelmanTJ, MannC, ZamoraJ, et al.. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and metaanalysis. Can Med Assoc J, 2008, 178(7): 855-862

[36] SuprasertP, SrisomboonJ, KasamatsuT. Radical hysterectomy for stage II B cervical cancer: a review. bit J Gynecol Cancer, 2005, 15(6): 995-1001

[37] NieblingMG, PleijhuisRG, BastiaannetE, et al.. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol, 2016, 42(4): 466-473

[38] SlomovitzBM, ColemanRL, OonkMH, et al.. Update on sentinel lymph node biopsy for early-stage vulvar cancer. Gynecol Oncol, 2015, 138(2): 472-477

[39] BatsAS, MathevetP, BuenerdA, et al.. The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol, 2013, 20(2): 413-422

[40] AltgassenC, HertelH, BrandstadtA, et al.. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO study group. J Clin Oncol, 2008, 26(18): 2943-2951

[41] LecuruF, MathevetP, QuerleuD, et al.. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol, 2011, 29(13): 1686-1691

[42] CormierB, DiazJP, ShihK, et al.. Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer. Gynecol Oncol, 2011, 122(2): 275-280

[43] SlamaJ, DundrP, DusekL, et al.. High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol, 2013, 29(2): 384-388

[44] SonodaK, YahataH, OkugawaK, et al.. Value of Intraoperative Cytological and Pathological Sentinel Lymph Node Diagnosis in Fertility-Sparing Trachelectomy for Early-Stage Cervical Cancer. Oncology, 2018, 94(2): 92-98

[45] CserniG. Intraoperative analysis of sentinel lymph nodes in breast cancer by one-step nucleic acid amplification. J Clin Pathol, 2012, 65(3): 193-199

[46] TamakiY. One-step nucleic acid amplification (OSNA): where do we go with it. Int J Clin Oncol, 2017, 22(1): 3-10

[47] OkamotoS, NiikuraH, NakabayashiK, et al.. Detection of sentinel lymph node metastases in cervical cancer: assessment of KRT19 mRNA in the one-step nucleic acid amplification (OSNA) method. Gynecol Oncol, 2013, 130(3): 530-536

[48] HornLC, HentschelB, FischerU, et al.. Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: frequency, topographic distribution and prognostic impact. Gynecol Oncol, 2008, 111(2): 276-281

[49] LentzSE, MuderspachLI, FelixJC, et al.. Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients. Obstet Gynecol, 2004, 103(6): 1204-1210

[50] MarchioleP, BuenerdA, BenchaibM, et al.. Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgicopathological study. Gynecol Oncol, 2005, 97(3): 727-732